Tumor Treating Field News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tumor treating field. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tumor Treating Field Today - Breaking & Trending Today

HC Wainwright Trims NovoCure (NASDAQ:NVCR) Target Price to $85.00

NovoCure (NASDAQ:NVCR – Get Rating) had its price target decreased by HC Wainwright from $115.00 to $85.00 in a research report report published on Wednesday morning, The Fly reports. HC Wainwright also issued estimates for NovoCure’s FY2025 earnings at ($3.27) EPS, FY2026 earnings at ($3.32) EPS and FY2027 earnings at ($2.46) EPS. Several other equities […] ....

Lazard Asset Management , Mcelhenny Sheffield Capital Management , Jpmorgan Chase Co , China Universal Asset Management Co , Harel Insurance Investments Financial Services Ltd , Novocure Ltd , Wells Fargo Company , Whittier Trust Co , Get Rating , Cure Trading Down , Elhenny Sheffield Capital Management , Asset Management , Universal Asset Management , Harel Insurance Investments , Financial Services , Insurance Investments , Tumor Treating Field , Novocure Daily ,

Wedbush Upgrades NovoCure (NASDAQ:NVCR) to Neutral

NovoCure (NASDAQ:NVCR – Get Rating) was upgraded by equities research analysts at Wedbush from an “underperform” rating to a “neutral” rating in a note issued to investors on Tuesday, The Fly reports. Several other equities analysts have also recently issued reports on NVCR. JPMorgan Chase & Co. reaffirmed an “underweight” rating and issued a $50.00 […] ....

Jpmorgan Chase Co , Wells Fargo Company , Norges Bank , Novocure Ltd , Nordwand Advisors , Hartline Investment Corp , Blackrock Inc , Pricet Rowe Associates Inc , Get Rating , Wells Fargo , Cure Stock Down , Tumor Treating Field , Novocure Daily , Nasdaq Nvcr ,

Thematics Asset Management Invests $7.93 Million in Exponent, Inc. (NASDAQ:EXPO)

NovoCure Limited (NASDAQ:NVCR – Get Rating) was the recipient of unusually large options trading on Tuesday. Stock traders purchased 5,873 call options on the company. This is an increase of 408% compared to the average volume of 1,157 call options. Institutional Investors Weigh In On NovoCure Institutional investors and hedge funds have recently added to […] ....

Novocure Limited , Norges Bank , Jpmorgan Chase Co , Hartline Investment Corp , Novocure Ltd , Wells Fargo Company , Pricet Rowe Associates Inc , Blackrock Inc , Nordwand Advisors , Get Rating , Cure Stock Down , Tumor Treating Field , Novocure Daily , Nasdaq Nvcr ,

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Sells 907 Shares of NovoCure Limited (NASDAQ:NVCR)

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lessened its holdings in NovoCure Limited (NASDAQ:NVCR – Get Rating) by 9.8% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 8,303 shares of the medical equipment provider’s stock after selling 907 shares during the quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp’s holdings in NovoCure were worth $609,000 at the […] ....

United Kingdom , Novocure Ltd , Assetmark Inc , Novocure Limited , Granite Investment Partners , Sequoia Financial Advisors , Jpmorgan Chase Co , Wells Fargo Company , Get Rating , Investment Partners , Cure Limited , Tumor Treating Field , Visit Holdingschannel , Novocure Daily , Nasdaq Nvcr , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,